J.B.CHEMICALS & PHARMACEUTICALS LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹2851.95
- Today's High:
- ₹3037.7
- Open Price:
- ₹2865.3999
- 52W Low:
- ₹1597.3961
- 52W High:
- ₹2770
- Prev. Close:
- ₹2842.3501
- Volume:
- 14043
Company Statistics
- Market Cap.:
- ₹190.30 billion
- Book Value:
- 320.693
- Revenue TTM:
- ₹31.49 billion
- Operating Margin TTM:
- 18.46%
- Gross Profit TTM:
- ₹19.81 billion
- Profit Margin:
- 13.01%
- Return on Assets TTM:
- 11.79%
- Return on Equity TTM:
- 17.75%
Company Profile
J.B.CHEMICALS & PHARMACEUTICALS LTD. had its IPO on under the ticker symbol JBCHEPHARM.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. J.B.CHEMICALS & PHARMACEUTICALS LTD. has a staff strength of 0 employees.
Stock update
Shares of J.B.CHEMICALS & PHARMACEUTICALS LTD. opened at ₹2865.4 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹2851.95 - ₹3037.7, and closed at ₹2926.8.
This is a +2.97% increase from the previous day's closing price.
A total volume of 14,043 shares were traded at the close of the day’s session.
In the last one week, shares of J.B.CHEMICALS & PHARMACEUTICALS LTD. have increased by +5.21%.
J.B.CHEMICALS & PHARMACEUTICALS LTD.'s Key Ratios
J.B.CHEMICALS & PHARMACEUTICALS LTD. has a market cap of ₹190.30 billion, indicating a price to book ratio of 6.8514 and a price to sales ratio of 5.6458.
In the last 12-months J.B.CHEMICALS & PHARMACEUTICALS LTD.’s revenue was ₹31.49 billion with a gross profit of ₹19.81 billion and an EBITDA of ₹6.96 billion. The EBITDA ratio measures J.B.CHEMICALS & PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, J.B.CHEMICALS & PHARMACEUTICALS LTD.’s operating margin was 18.46% while its return on assets stood at 11.79% with a return of equity of 17.75%.
In Q1, J.B.CHEMICALS & PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 2.1% while revenue growth was a positive 22.1%.
J.B.CHEMICALS & PHARMACEUTICALS LTD.’s PE and PEG Ratio
- Forward PE
- 26.1097
- Trailing PE
- 47.0459
- PEG
Its diluted EPS in the last 12-months stands at ₹52.25 per share while it has a forward price to earnings multiple of 26.1097 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into J.B.CHEMICALS & PHARMACEUTICALS LTD.’s profitability.
J.B.CHEMICALS & PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 5.678 and a EV to EBITDA ratio of 25.8679. Its price to sales ratio in the trailing 12-months stood at 5.6458.
J.B.CHEMICALS & PHARMACEUTICALS LTD. stock pays annual dividends of ₹17.75 per share, indicating a yield of 0.74% and a payout ratio of 31.38%.
Balance sheet and cash flow metrics
- Total Assets
- ₹35.54 billion
- Total Liabilities
- ₹5.54 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 31.38%
J.B.CHEMICALS & PHARMACEUTICALS LTD. ended 2024 with ₹35.54 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹35.54 billion while shareholder equity stood at ₹24.80 billion.
J.B.CHEMICALS & PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹5.54 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹574.60 million in goodwill. Its cash balance stood at ₹769.30 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹3.83 billion.
J.B.CHEMICALS & PHARMACEUTICALS LTD.’s total current assets stands at ₹15.28 billion while long-term investments were ₹0 and short-term investments were ₹2.16 billion. Its net receivables were ₹5.76 billion compared to accounts payable of ₹2.39 billion and inventory worth ₹4.30 billion.
In 2024, J.B.CHEMICALS & PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, J.B.CHEMICALS & PHARMACEUTICALS LTD. paid ₹0.31 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹2926.8
- 52-Week High
- ₹2770
- 52-Week Low
- ₹1597.3961
- Analyst Target Price
- ₹
J.B.CHEMICALS & PHARMACEUTICALS LTD. stock is currently trading at ₹2926.8 per share. It touched a 52-week high of ₹2770 and a 52-week low of ₹2770. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹2610.63 and 200-day moving average was ₹2177.03 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5431.2% of the company’s stock are held by insiders while 2271.4% are held by institutions.
Frequently Asked Questions About J.B.CHEMICALS & PHARMACEUTICALS LTD.
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.